Routine Elastin Staining in Surgically Resected Colorectal Cancer: Impact on Venous Invasion Detection and its Association With Oncologic Outcomes.


Journal

The American journal of surgical pathology
ISSN: 1532-0979
Titre abrégé: Am J Surg Pathol
Pays: United States
ID NLM: 7707904

Informations de publication

Date de publication:
01 02 2022
Historique:
pubmed: 20 8 2021
medline: 15 2 2022
entrez: 19 8 2021
Statut: ppublish

Résumé

Venous invasion (VI) is a powerful yet underreported prognostic factor in colorectal cancer (CRC). Its detection can be improved with an elastin stain. We evaluated the impact of routine elastin staining on VI detection in resected CRC and its relationship with oncologic outcomes. Pathology reports from the year before (n=145) and the year following (n=128) the implementation of routine elastin staining at our institution were reviewed for established prognostic factors, including VI. A second review, using elastin stains, documented the presence/absence, location, number, and size of VI foci. The relationship between VI and oncologic outcomes was evaluated for original and review assessments. VI detection rates increased from 21% to 45% following implementation of routine elastin staining (odds ratio [OR]=3.1; 95% confidence interval [CI]: 1.8-5.3; P<0.0001). The second review revealed a lower VI miss rate postimplementation than preimplementation (22% vs. 48%, respectively; P=0.007); this difference was even greater for extramural VI-positive cases (9% vs. 38%, respectively; P=0.0003). Missed VI cases postimplementation had fewer VI foci per missed case (P=0.02) and a trend towards less extramural VI than those missed preimplementation. VI assessed with an elastin stain was significantly associated with recurrence-free survival (P=0.003), and cancer-specific survival (P=0.01) in contrast to VI assessed on hematoxylin and eosin alone (P=0.053 and 0.1, respectively). The association between VI and hematogenous metastasis was far stronger for elastin-detected VI (OR=11.5; 95% CI: 3.4-37.1; P<0.0001) than for hematoxylin and eosin-detected VI (OR=3.7; 95% CI: 1.4-9.9; P=0.01). Routine elastin staining enhances VI detection and its ability to stratify risk in CRC and should be considered for evaluation of CRC resection specimens.

Identifiants

pubmed: 34411028
doi: 10.1097/PAS.0000000000001790
pii: 00000478-202202000-00006
doi:

Substances chimiques

Azo Compounds 0
Biomarkers, Tumor 0
Coloring Agents 0
ELN protein, human 0
trichrome stain 0
Methyl Green 82-94-0
Elastin 9007-58-3
Eosine Yellowish-(YS) TDQ283MPCW

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

200-212

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest and Source of Funding: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.

Références

Chapuis PH, Dent OF, Fisher R, et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg. 1985;72:698–702.
Freedman L, Macaskill P, Smith A. Multivariate analysis of prognostic factors for operable rectal cancer. Lancet. 1984;2:733–736.
Harrison JC, Dean PJ, El-zeky F, et al. From dukes through jass: pathological prognostic indicators in rectal cancer. Hum Pathol. 1994;25:498–505.
Heys SD, Sherif A, Bagley JS, et al. Prognostic factors and survival of patients aged less than 45 years with colorectal cancer. Br J Surg. 1994;81:685–688.
Horn A, Dahl O, Morild I. Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Dis Colon Rectum. 1991;34:798–804.
Quirke P, Morris E. Reporting colorectal cancer. Histopathology. 2007;50:103–112.
Sato T, Ueno H, Mochizuki H, et al. Objective criteria for the grading of venous invasion in colorectal cancer. Am J Surg Pathol. 2010;34:454–462.
Chan YM, MacKay C, Ritchie DT, et al. Screen detection is a survival predictor independent of pathological grade in colorectal cancer. A prospective cohort study. Surgeon. 2021;19:20–26.
Shin YM, Pyo JS, Park MJ. The impact of extramural venous invasion in colorectal cancer: a detailed analysis based on tumor location and evaluation methods. Int J Surg Pathol. 2020;28:120–127.
Betge J, Pollheimer MJ, Lindtner RA, et al. Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer. 2012;118:628–638.
Roxburgh CSD, McMillan DC, Anderson JH, et al. Elastica staining for venous invasion results in superior prediction of cancer-specific survival in colorectal cancer. Ann Surg. 2010;252:989–997.
Roxburgh CSD, Mcmillan DC, Richards CH, et al. The clinical utility of the combination of T stage and venous invasion to predict survival in patients undergoing surgery for colorectal cancer. Ann Surg. 2014;259:1156–1165.
Leijssen LGJ, Dinaux AM, Amri R, et al. Impact of intramural and extramural vascular invasion on stage II-III colon cancer outcomes. J Surg Oncol. 2019;119:749–757.
Shepherd NA, Baxter KJ, Love SB. Influence of local peritoneal involvement on pelvic recurrence and prognosis in rectal cancer. J Clin Pathol. 1995;48:849–855.
Talbot IC, Ritchie S, Leighton MH, et al. Spread of rectal cancer within veins. Histologic features and clinical significance. Am J Surg. 1981;141:15–17.
Cyr D, Akder A, Shivji S, et al. extramural venous invasion detected with an elastin stain is a powerful predictor of cancer-specific mortality in stage I-IIIB resected colorectal cancer (CRC). Ann Oncol. 2020;31(suppl 15):S133.
Messenger DE, Cohen Z, Kirsch R, et al. Favorable pathologic and long-term outcomes from the conventional approach to abdominoperineal resection. Dis Colon Rectum. 2011;54:793–802.
Maughan NJ, Morris E, Forman D, et al. The validity of the Royal College of Pathologists’ colorectal cancer minimum dataset within a population. Br J Cancer. 2007;97:1393–1398.
Messenger DE, Driman DK, Kirsch R. Developments in the assessment of venous invasion in colorectal cancer: Implications for future practice and patient outcome. Hum Pathol. 2012;43:965–973.
Kirsch R, Messeng DE, Riddell RH, et al. Venous invasion in colorectal cancer: impact of an elastin stain on detection and interobserver agreement among gastrointestinal and nongastrointestinal pathologists. Am J Pathol. 2013;37:200–210.
Sejben I, Bori R, Cserni G. Venous invasion demonstrated by orcein staining of colorectal carcinoma specimens is associated with the development of distant metastasis. J Clin Pathol. 2010;63:575–578.
Howlett CJ, Tweedie EJ, Driman DK. Use of an elastic stain to show venous invasion in colorectal carcinoma: a simple technique for detection of an important prognostic factor. J Clin Pathol. 2009;62:1021–1025.
Vass DG, Ainsworth R, Anderson JH, et al. The value of an elastic tissue stain in detecting venous invasion in colorectal cancer. J Clin Pathol. 2004;57:769–772.
Kingston EF, Goulding H, Bateman AC. Vascular invasion is underrecognized in colorectal cancer using conventional hematoxylin and eosin staining. Dis Colon Rectum. 2007;50:1867–1872.
Inoue T, Mori M, Shimono R, et al. Vascular invasion of colorectal carcinoma readily visible with certain stains. Dis Colon Rectum. 1992;35:34–39.
Suzuki A, Togashi K, Nokubi M, et al. Evaluation of venous invasion by Elastica van Gieson stain and tumor budding predicts local and distant metastases in patients with T1 stage colorectal cancer. Am J Pathol. 2009;33:1601–1607.
Burgart LJ, Kakar S, Shi C, College of American Pathologists, et al. Protocol for the examination of resection specimens from patients with primary carcinoma of the colon and rectum, version 4.1.0.0; 2020. Available at: https://documents.cap.org/protocols/cp-gilower-colonrectum-resection-20-4100.pdf . Accessed March 10, 2021.
Loughrey M, Arends M, Brown I, et al. Colorectal Cancer Histopathology Reporting Guide. Sydney, NSW, Australia: International Collaboration on Cancer Reporting; 2020.
Loughrey M, Quirke P, Shepherd NA. The Royal College of Pathologists. Dataset for histopathological reporting of colorectal cancer. Standards and datasets for reporting cancers; 2018. Available at: www.rcpath.org/uploads/assets/c8b61ba0-ae3f-43f1-85ffd3ab9f17cfe6/G049-Dataset-for-histopathological-reporting-of-colorectal-cancer.pdf . Accessed March 10, 2021.
Watanabe T, Muro K, Ajioka Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol. 2018;23:1–34.
The Royal College of Pathologists of Australasia. Colorectal Cancer Structured Reporting Protocol (Version 4.0), 4th edition; 2020:1–77. Available at: www.rcpa.edu.au/Library/Practising-Pathology/Structured-Pathology-Reporting-of-Cancer/Cancer-Protocols/Gastrointestinal/Protocol-colorectal-cancer . Accessed March 10, 2021.
Kirsch R, Messenger DE, Shepherd N, et al. Wide variability in assessment and reporting of colorectal cancer specimens among north american pathologists: results of a Canada-US Survey. Can J Pathol. 2019;11:58–69.
Members of the Colorectal Cancer Survivorship Group. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: Program in Evidence-based Care Evidence-Based Series No.: 26-2 Version 3. Toronto, ON: Ontario Health (Cancer Care Ontario); 2021:1–77.
Cyr D, Kirsch R, Brar A, et al. Multifocal extramural venous invasion detected with an elastin stain as a predictor of cancer-specific outcomes in stage I-III resected colorectal cancer (CRC). J Clin Oncol. 2021;39(suppl 3):114.
Shirouzu K, Isomoto H, Kakegawa T, et al. A prospective clinicopathologic study of venous invasion in colorectal cancer. Am J Pathol. 1991;162:216–222.

Auteurs

Aysegul Sari (A)

Department of Pathology and Laboratory Medicine.
Department of Pathology, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey.

David P Cyr (DP)

Lunenfeld-Tanenbaum Research Institute, Sinai Health System.
Department of Surgical Oncology, Princess Margaret Cancer Centre and Mount Sinai Hospital.
Department of Surgery, Division of General Surgery.
Institute of Medical Science.

Amanpreet Brar (A)

Department of Surgery, Division of General Surgery.

David E Messenger (DE)

Division of General Surgery, Royal United Hospital NHS Trust, Bath, UK.

David K Driman (DK)

Department of Pathology, London Health Sciences Centre and Western University, London, ON, Canada.

Sameer Shivji (S)

Department of Pathology and Laboratory Medicine.

Naziheh Assarzadegan (N)

Department of Pathology and Laboratory Medicine, The Johns Hopkins Hospital, Baltimore, MD.

Ari Juda (A)

Department of Pathology and Laboratory Medicine.

Carol J Swallow (CJ)

Lunenfeld-Tanenbaum Research Institute, Sinai Health System.
Department of Surgical Oncology, Princess Margaret Cancer Centre and Mount Sinai Hospital.
Department of Surgery, Division of General Surgery.
Institute of Medical Science.

Erin D Kennedy (ED)

Department of Surgical Oncology, Princess Margaret Cancer Centre and Mount Sinai Hospital.
Department of Surgery, Division of General Surgery.

Mantaj S Brar (MS)

Department of Surgery, Division of General Surgery.

James Conner (J)

Department of Pathology and Laboratory Medicine.
Lunenfeld-Tanenbaum Research Institute, Sinai Health System.
Department of Pathobiology and Laboratory Medicine, University of Toronto, Toronto.

Richard Kirsch (R)

Department of Pathology and Laboratory Medicine.
Lunenfeld-Tanenbaum Research Institute, Sinai Health System.
Department of Pathobiology and Laboratory Medicine, University of Toronto, Toronto.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH